Another study [49] also reported that a low dose of FGF1 administered intracerebroventricularly resulted in sustained diabetes remission in mouse and rat models of T2DM, but it did not reduce corticosterone levels, suggesting that the role of the HPA axis in diabetes remission is questionable. Here, FGF1 is linked to diabetes mellitus.